Associated Papers
Identification and Computational Analysis of Novel Pathogenic Variants in Pakistani Families with Diverse Epidermolysis Bullosa Phenotypes.
Khan FF et al.
Biomolecules, 2021
Using immunofluorescence (antigen) mapping in the diagnosis and classification of epidermolysis bullosa: a first report from Iran.
Barzegar M et al.
International Journal of Dermatology, 2015
A new homozygous nonsense mutation in LAMA3A underlying laryngo-onycho-cutaneous syndrome.
Barzegar M et al.
The British Journal of Dermatology, 2013
Efficiency of translation termination in humans is highly dependent upon nucleotides in the neighbourhood of a (premature) termination codon.
Pacho F et al.
Journal of Medical Genetics, 2011
Biological function of laminin-5 and pathogenic impact of its deficiency.
Schneider H et al.
European Journal of Cell Biology, 2007
Granulation tissue in the eyelid margin and conjunctiva in junctional epidermolysis bullosa with features of laryngo-onycho-cutaneous syndrome.
Figueira EC et al.
Clinical & Experimental Ophthalmology, 2007
Epidermolysis bullosa. I. Molecular genetics of the junctional and hemidesmosomal variants.
Varki R et al.
Journal of Medical Genetics, 2006
The alpha-3 polypeptide chain of laminin 5: insight into wound healing responses from the study of genodermatoses.
Hamill KJ et al.
Clinical and Experimental Dermatology, 2005
An unusual N-terminal deletion of the laminin alpha3a isoform leads to the chronic granulation tissue disorder laryngo-onycho-cutaneous syndrome.
McLean WH et al.
Human Molecular Genetics, 2003
Laminin 332 in junctional epidermolysis bullosa.
Kiritsi D et al.
Cell Adhesion & Migration, 0
Select a paper to view details